Spruce Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview

Spruce Biosciences

05/05/2023 15:06

* Spruce Biosciences Inc  SPRB.OQ   SPRB.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 9
(estimated). 
    * The South San Francisco California-based  company is
expected to
report revenue of $500 thousand, according to the mean estimate
from 3 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Spruce Biosciences
Inc is
for a loss of 36 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $8​, above​ its last closing price of $2.35.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.56       -0.53      -0.47     Beat    11.3
 Sep. 30 2022  -0.54       -0.53      -0.48     Beat    10.3
 Jun. 30 2022  -0.53       -0.52      -0.51     Beat    2.9​
 Mar. 31 2022  -0.46       -0.46      -0.50     Missed  -9.1
 ​​Dec.        -0.54       -0.54      -0.39     Beat    27.8
 31 2021                                                
 Sep. 30 2021  -0.58       -0.57      -0.49     Beat    14.4​
 Jun. 30 2021  -0.45       -0.45      -0.50     Missed  -11.1
 Mar. 31 2021  -0.42       -0.42      -0.42     Met     0.8
 This summary was machine generated May 5 at 14:06 GMT.  All
figures in US dollars  unless otherwise stated